Araj-Khodaei M, Ayati MH, Azizi Zeinalhajlou A, et al
But the evidence shows: Pancreatitis is rare Most cases are not caused by GLP-1s Gallstones and rapid weight loss are more likely culprits The benefits of GLP-1 therapy for obesity and diabetes are significant With proper supervision, GLP-1 medications remain safe and effective tools in managing chronic metabolic disease.
Semaglutide vs Tirezepatide for Weight Loss in Adults With Overweight or Obesity
Mounjaros prescribing information also says nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain are the most common adverse events, and that Mounjaro delays gastric emptying, which may impact medication absorption